175 related articles for article (PubMed ID: 11810081)
1. Polycystic ovary syndrome: a risk for coronary artery disease?
Wild RA
Am J Obstet Gynecol; 2002 Jan; 186(1):35-43. PubMed ID: 11810081
[TBL] [Abstract][Full Text] [Related]
2. Understanding the underlying metabolic abnormalities of polycystic ovary syndrome and their implications.
Taylor AE
Am J Obstet Gynecol; 1998 Dec; 179(6 Pt 2):S94-S100. PubMed ID: 9855615
[TBL] [Abstract][Full Text] [Related]
3. Polycystic ovarian syndrome: the next cardiovascular dilemma in women?
Srikanthan P; Korenman S; Davis S
Endocrinol Metab Clin North Am; 2006 Sep; 35(3):611-31, x. PubMed ID: 16959589
[TBL] [Abstract][Full Text] [Related]
4. Polycystic ovary syndrome, diabetes and cardiovascular disease: risks and risk factors.
Lakhani K; Prelevic GM; Seifalian AM; Atiomo WU; Hardiman P
J Obstet Gynaecol; 2004 Sep; 24(6):613-21. PubMed ID: 16147598
[TBL] [Abstract][Full Text] [Related]
5. Metabolic consequences of obesity and insulin resistance in polycystic ovary syndrome: diagnostic and methodological challenges.
Jeanes YM; Reeves S
Nutr Res Rev; 2017 Jun; 30(1):97-105. PubMed ID: 28222828
[TBL] [Abstract][Full Text] [Related]
6. Obesity, lipids, cardiovascular risk, and androgen excess.
Wild RA
Am J Med; 1995 Jan; 98(1A):27S-32S. PubMed ID: 7825638
[TBL] [Abstract][Full Text] [Related]
7. Current perspectives of insulin resistance and polycystic ovary syndrome.
Pauli JM; Raja-Khan N; Wu X; Legro RS
Diabet Med; 2011 Dec; 28(12):1445-54. PubMed ID: 21950959
[TBL] [Abstract][Full Text] [Related]
8. Assessment of cardiovascular risk and prevention of cardiovascular disease in women with the polycystic ovary syndrome: a consensus statement by the Androgen Excess and Polycystic Ovary Syndrome (AE-PCOS) Society.
Wild RA; Carmina E; Diamanti-Kandarakis E; Dokras A; Escobar-Morreale HF; Futterweit W; Lobo R; Norman RJ; Talbott E; Dumesic DA
J Clin Endocrinol Metab; 2010 May; 95(5):2038-49. PubMed ID: 20375205
[TBL] [Abstract][Full Text] [Related]
9. Polycystic ovarian syndrome (PCOS): Long-term metabolic consequences.
Anagnostis P; Tarlatzis BC; Kauffman RP
Metabolism; 2018 Sep; 86():33-43. PubMed ID: 29024702
[TBL] [Abstract][Full Text] [Related]
10. [Chronic complications of polycystic ovary syndrome. Review].
Velásquez E
Invest Clin; 2002 Sep; 43(3):205-13. PubMed ID: 12229282
[TBL] [Abstract][Full Text] [Related]
11. High-sensitivity C-reactive protein (hs-CRP) levels and its relationship with components of polycystic ovary syndrome in Indian adolescent women with polycystic ovary syndrome (PCOS).
Ganie MA; Hassan S; Nisar S; Shamas N; Rashid A; Ahmed I; Douhat S; Mudassar S; Jan VM; Rashid F
Gynecol Endocrinol; 2014 Nov; 30(11):781-4. PubMed ID: 25137507
[TBL] [Abstract][Full Text] [Related]
12. Cardiometabolic features of polycystic ovary syndrome.
Hoffman LK; Ehrmann DA
Nat Clin Pract Endocrinol Metab; 2008 Apr; 4(4):215-22. PubMed ID: 18250636
[TBL] [Abstract][Full Text] [Related]
13. Polycystic ovary syndrome and the risk of cardiometabolic complications in longitudinal studies.
Jacewicz-Święcka M; Kowalska I
Diabetes Metab Res Rev; 2018 Nov; 34(8):e3054. PubMed ID: 30089337
[TBL] [Abstract][Full Text] [Related]
14. Young obese women with polycystic ovary syndrome have evidence of early coronary atherosclerosis.
Shroff R; Kerchner A; Maifeld M; Van Beek EJ; Jagasia D; Dokras A
J Clin Endocrinol Metab; 2007 Dec; 92(12):4609-14. PubMed ID: 17848406
[TBL] [Abstract][Full Text] [Related]
15. Do women with polycystic ovary syndrome have an increased risk of cardiovascular disease? Review of the evidence.
Talbott EO; Zborowskii JV; Boudraux MY
Minerva Ginecol; 2004 Feb; 56(1):27-39. PubMed ID: 14973408
[TBL] [Abstract][Full Text] [Related]
16. Metabolic and cardiovascular consequences of polycystic ovary syndrome.
Orio F; Vuolo L; Palomba S; Lombardi G; Colao A
Minerva Ginecol; 2008 Feb; 60(1):39-51. PubMed ID: 18277351
[TBL] [Abstract][Full Text] [Related]
17. Glucose intolerance in obese adolescents with polycystic ovary syndrome: roles of insulin resistance and beta-cell dysfunction and risk of cardiovascular disease.
Arslanian SA; Lewy VD; Danadian K
J Clin Endocrinol Metab; 2001 Jan; 86(1):66-71. PubMed ID: 11231980
[TBL] [Abstract][Full Text] [Related]
18. Comorbidities in polycystic ovary syndrome: their relationship to insulin resistance.
Bethea SW; Nestler JE
Panminerva Med; 2008 Dec; 50(4):295-304. PubMed ID: 19078870
[TBL] [Abstract][Full Text] [Related]
19. Cardiovascular health in women with polycystic ovary syndrome.
Sukalich S; Guzick D
Semin Reprod Med; 2003 Aug; 21(3):309-15. PubMed ID: 14593554
[TBL] [Abstract][Full Text] [Related]
20. The insulin resistance syndrome.
Smolar EN
Compr Ther; 1997 Apr; 23(4):237-43. PubMed ID: 9167914
[No Abstract] [Full Text] [Related]
[Next] [New Search]
